MS

Michael Schmidt Guggenheim Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
IMNM icon
1
Immunome
IMNM
$853M
$9.80 $25
155%
upside
Buy 10 days ago
ADCT icon
2
ADC Therapeutics
ADCT
$382M
$3.40 $10
194%
upside
Buy 22 days ago
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.05B
$10.77 $18
67%
upside
Buy 22 days ago
CMPX icon
4
Compass Therapeutics
CMPX
$466M
$3.37 $12
256%
upside
Buy 23 days ago
ONC
5
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.1B
$318.73 $365
15%
upside
Buy 28 days ago
ARVN icon
6
Arvinas
ARVN
$559M
$7.61 $15
97%
upside
Buy 28 days ago
TNGX icon
7
Tango Therapeutics
TNGX
$760M
$6.83 $10
46%
upside
Buy 29 days ago
COGT icon
8
Cogent Biosciences
COGT
$1.81B
$12.94 $17
31%
upside
Buy 1 month ago
RVMD icon
9
Revolution Medicines
RVMD
$7.28B
$38.95 $80
105%
upside
Buy 2 months ago
AVBP icon
10
ArriVent BioPharma
AVBP
$792M
$19.52 $45
131%
upside
Buy 2 months ago
URGN icon
11
UroGen Pharma
URGN
$870M
$18.80 $15
20%
downside
Buy 3 months ago
KYMR icon
12
Kymera Therapeutics
KYMR
$3.02B
$42.20 $52
23%
upside
Buy 3 months ago
RLAY icon
13
Relay Therapeutics
RLAY
$690M
$4 $10
150%
upside
Buy 4 months ago
SNDX icon
14
Syndax Pharmaceuticals
SNDX
$1.39B
$16.19 $32
98%
upside
Buy 4 months ago
NBTX
15
Nanobiotix
NBTX
$411M
$8.52 $8
6%
downside
Buy 5 months ago
MRUS icon
16
Merus
MRUS
$5.01B
$66.23 $109
65%
upside
Buy 5 months ago
VSTM icon
17
Verastem
VSTM
$650M
$10.56 $14
33%
upside
Buy 5 months ago
INCY icon
18
Incyte
INCY
$16.7B
$85.44 $92
8%
upside
Neutral 5 months ago
EXEL icon
19
Exelixis
EXEL
$10.1B
$37.38 $42
12%
upside
Buy 6 months ago
XNCR icon
20
Xencor
XNCR
$597M
$8.37 $34
306%
upside
Buy 1 year ago
ERAS icon
21
Erasca
ERAS
$420M
$1.48 $25
1,589%
upside
Buy 4 years ago
GLUE icon
22
Monte Rosa Therapeutics
GLUE
$303M
$4.91 $30
511%
upside
Buy 4 years ago